Physician profile
Eric E Shoup
NPI 1073576781
$73,689.43
in general payments reported to CMS, 2019-2025
36 companies · $7,360 in 2025
The $7,360 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23K · 2022: $14K · 2023: $19K · 2024: $10K · 2025: $7,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $9,646 · Food and Beverage: $7,708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,325.00 |
| Travel and Lodging | $9,645.81 |
| Food and Beverage | $7,708.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $47,210.58 | 2021-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $15,723.45 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $1,988.27 | 2021-2025 | |
| Cmp Pharma, INC. | $1,396.12 | 2021-2023 | Atorvaliq |
| E.R. Squibb & Sons, L.L.C. | $923.56 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $851.71 | 2021-2025 | Farxiga, Wainua, Brilinta |
| Pfizer INC. | $709.93 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $577.33 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $492.71 | 2022-2025 | Onpattro |
| Philips North America LLC | $466.32 | 2022-2025 | Event, (Ck4) Mcot, (Ck6) Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $439.01 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $435.54 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $376.84 | 2021-2025 | Cds - Mct/Cem Monitoring, Bodyguardian, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $337.39 | 2021-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $241.23 | 2022-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | $228.78 | 2021-2023 | Arcalyst |
| Scpharmaceuticals INC. | $185.85 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $138.97 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $129.01 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Abbott Laboratories | $119.63 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Novo Nordisk INC | $110.18 | 2025 | Wegovy |
| Chiesi USA, INC. | $103.81 | 2023 | Kengreal |
| Lexicon Pharmaceuticals, INC. | $58.79 | 2024 | |
| Arbor Pharmaceuticals, INC. | $53.57 | 2021 | |
| Edwards Lifesciences Corporation | $52.89 | 2022-2024 | Sapien 3 Ultra Resilia |
| Regeneron Healthcare Solutions, INC. | $50.70 | 2021-2022 | |
| Atricure, INC. | $49.68 | 2024-2025 | Synergy Ablation System |
| Cvrx, INC. | $42.58 | 2023 | Barostim Neo System |
| Medtronic, INC. | $40.00 | 2022 | |
| Bridgebio Pharma, INC. | $28.67 | 2025 | Attruby |
| Jazz Pharmaceuticals INC. | $28.37 | 2025 | |
| Corcept Therapeutics | $22.56 | 2025 | Korlym |
| Impulse Dynamics (USA) INC. | $21.76 | 2023 | Optimizer |
| Genzyme Corporation | $20.45 | 2023 | |
| Mallinckrodt Hospital Products INC. | $17.83 | 2022 | |
| Abiomed | $15.36 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shoup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.